Emerging Neurobiology of Antidepressant Tr...

Dekorationsartikel gehören nicht zum Leistungsumfang.

Sprache: Englisch

178,95 €

UVP 213,99 €

inkl. MwSt.

Versandkostenfrei per Post / DHL

Lieferzeit 1-2 Wochen

Kategorien:

Beschreibung

This volume is unique in bringing the exciting range of antidepressant treatment developments together with a focus on their neurobiological mechanisms and how these interact with the known pathophysiology of depression. Current evidence for treatment efficacy is reviewed together with a discussion of where in the management pathway of this common condition, these new approaches might take their place.

Inhaltsverzeichnis

SSRIs A pharmacological cul-de-sac.- Neurobiology of SSRI withdrawal.- Pramipexole in the treatment of depression.- Opioid mechanisms in the treatment of depression.- Neuropsychological effects of antidepressants-translational studies.- KETAMINE FOR MAJOR DEPRESSIVE DISORDER.- Psilocybin and other classic psychedelics in depression.- Gut-brain axis and antidepressant treatment.- Anti-inflammatory drugs in the treatment of depression.- Mechanisms of TMS in Depression.- Mechanism of action of ECT in depression.- Vagal nerve stimulation in the treatment of depression.

Details

Erscheinungsjahr:	2024
Fachbereich:	Therapie
Genre:	Mathematik , Medizin , Naturwissenschaften , Technik
Rubrik:	Wissenschaften
Medium:	Buch
Inhalt:	x 311 S. 70 s/w Illustr. 30 farbige Illustr. 311 p. 100 illus. 30 illus. in color.
ISBN-13:	9783031663550
ISBN-10:	3031663551
Sprache:	Englisch
Einband:	Gebunden
Redaktion:	Browning, Michael Sharp, Trevor Cowen, Philip J.
Herausgeber:	Michael Browning/Philip J Cowen/Trevor Sharp
Hersteller:	Springer Nature Switzerland Springer International Publishing Springer International Publishing AG
Verantwortliche Person für die EU:	Springer Verlag GmbH, Tiergartenstr. 17, D-69121 Heidelberg, juergen.hartmann@springer.com
Maße:	241 x 160 x 24 mm
Von/Mit:	Michael Browning (u. a.)
Erscheinungsdatum:	25.07.2024
Gewicht:	0,653 kg